Home > Insider Trading > Filing (0001209191-21-045825)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1237831	Globus Medical Inc	GMED	Surgical & Medical Instruments & Apparatus (3841)	043744954

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1642439	T Daniel Scavilla	Valley Forge Business Center 2560 General Armistead Avenue Audubon PA 19403	Evp, Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2021-07-02	50,000	$25.52	50,000	No	4	M	Direct
Class A Common Stock	Acquisiton	2021-07-02	50,000	$26.27	100,000	No	4	M	Direct
Class A Common Stock	Disposition	2021-07-02	99,600	$78.41	400	No	4	S	Direct
Class A Common Stock	Disposition	2021-07-02	400	$78.97	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (Right to buy Class A Common Stock)	Disposition	2021-07-02	50,000	$0.00	50,000	$25.52
Class A Common Stock	Stock Option (Right to Buy Class A Common Stock)	Disposition	2021-07-02	50,000	$0.00	50,000	$26.27

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-01-25	No	4	M	Direct
30,000		2027-01-30	No	4	M	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.83 to $78.69, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.